NEW YORK, NY / ACCESSWIRE / January 11, 2021 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies who purchased shares within the class periods listed below. Shareholders interested in representing the class of wronged shareholders have until the lead plaintiff deadline to petition the court. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. For more details and to speak with our firm without cost or obligation, follow the links below.
Berry Corporation (NASDAQ:BRY)
CONTACT JAKUBOWITZ ABOUT BRY:
https://claimyourloss.com/securities/berry-corporation-loss-submission-form/?id=12072&from=1
Lawsuit on behalf of investors who purchased: (a) Berry common stock pursuant and/or traceable to the Company’s initial public offering conducted on or about July 26, 2018; or (b) Berry securities between July 26, 2018 and November 3, 2020, both dates inclusive
Lead Plaintiff Deadline : January 21, 2021
The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (i) Berry had materially overstated its operational efficiency and stability; (ii) Berry’s operational inefficiency and instability would foreseeably necessitate operational improvements that would disrupt the Company’s productivity and increase costs; (iii) the foregoing would foreseeably negatively impact the Company’s revenues; and (iv) as a result, the Offering Documents and the Company’s public statements were materially false and/or misleading and failed to state information required to be stated therein.
Qiwi plc (NASDAQ:QIWI)
CONTACT JAKUBOWITZ ABOUT QIWI:
https://claimyourloss.com/securities/qiwi-plc-loss-submission-form/?id=12072&from=1
Class Period : March 28, 2019 - December 9, 2020
Lead Plaintiff Deadline : February 9, 2021
The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) Qiwi’s internal controls related to reporting and record-keeping were ineffective; (2) consequently, the Central Bank of Russia would impose a monetary fine upon the Company and impose restrictions upon the Company’s ability to make payments to foreign merchants and transfer money to pre-paid cards; and (3) as a result, Defendants’ public statements were materially false and/or misleading at all relevant times.
Tricida, Inc. (NASDAQ:TCDA)
CONTACT JAKUBOWITZ ABOUT TCDA:
https://claimyourloss.com/securities/tricida-inc-loss-submission-form/?id=12072&from=1
Class Period : September 4, 2019 - October 28, 2020
Lead Plaintiff Deadline : March 8, 2021
The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (i) Tricida’s NDA for veverimer was materially deficient; (ii) accordingly, it was foreseeably likely that the FDA would not accept the NDA for veverimer; and (iii) as a result, the Company’s public statements were materially false and misleading at all relevant times.
Jakubowitz Law is vigorous in pursuit of justice for shareholders who have been the victim of securities fraud. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
JAKUBOWITZ LAW
1140 Avenue of the Americas
9th Floor
New York, New York 10036
T: (212) 867-4490
F: (212) 537-5887
SOURCE: Jakubowitz Law